PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Other Liabilities
$100.6m
CAGR 3-Years
-32%
CAGR 5-Years
-23%
CAGR 10-Years
47%
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.4B
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$2.2B
CAGR 3-Years
-28%
CAGR 5-Years
-22%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$4.6B
CAGR 3-Years
-19%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.5B
CAGR 3-Years
30%
CAGR 5-Years
57%
CAGR 10-Years
37%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.7B
CAGR 3-Years
37%
CAGR 5-Years
11%
CAGR 10-Years
23%

See Also

What is PTC Therapeutics Inc's Other Liabilities?
Other Liabilities
100.6m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Other Liabilities amounts to 100.6m USD.

What is PTC Therapeutics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
47%

Over the last year, the Other Liabilities growth was -27%. The average annual Other Liabilities growth rates for PTC Therapeutics Inc have been -32% over the past three years , -23% over the past five years , and 47% over the past ten years .

Back to Top